Annually, millions of patients in EU and US intensive care units (ICUs) are unable to communicate, resulting in multibillion euro loss. Lack of communication leads to disorientation and higher rates of Delirium, a serious mental disturbance resulting in confused thinking and reduced awareness. Delirium affects 60-80% of intubated ICU patients ; it is estimated to cost the US healthcare system $6B-20B annually.
COVID-19 patients requiring respiratory support are unable to communicate through conventional methods; and, medical staff in close proximity have an increased likelihood of contagion. A remote communication solution is needed to safeguard hospital workforces.
EyeFree Assisting Communication Ltd. is a pioneer of medical technology, specializing in innovative communication solutions that address unmet healthcare needs. We implement disruptive AI-technologies that connect people and bridge information barriers, facilitating better medical care and decision-making.
Our eye-tracking wearable and smart platforms empower communication between patients who cannot speak, their families, and medical teams.
EyeFree’s cutting-edge medical innovations are the first of their kind for acute and home care settings:
1. EyeControl-Med is a communication solution for healthcare facilities, enabling remote connectivity between the patient’s headset, nurse work station, and loved ones from afar. It aims to drive improved clinical outcomes via real-time analytics, and revolutionize the industry standard for medical communication.
2. EyeControl–Home is a comprehensive communication solution for patients transitioning from medical facilities to remote home care and other Locked-in patients, who cannot speak. It improves quality of life by providing round-the-clock connectivity and freedom of expression.
This project is focused on robust technological developments that will expedite EyeFree’s entry to the medical facilities market (EyeControl-Med). Short-term demand in this segment is growing; the unmet need for ICU communication already existed, and has been further exasperated by an influx of ventilation caused by the Coronavirus. There are no comprehensive solutions on the market; and, that places EyeControl-Med at the forefront, as an immediate and effective technology, facilitating easy and safe communication between patients, medical staff, caregivers, and families, and leading to higher quality care. Once this niche market has been consolidated, we will boost the market entry and be known as the global communication platform for both ventilated and Locked-in patients.
